Riverstone HoldingsSGX:AP4 +2.41%63 ROA % is 13.26% as of Dec. 2025, which is 17% below its 10-year median of 16.03. GuruFocus rates SGX:AP4 with a GF Score™ of 63/100 and a GF Value™ of S$0.86 (Fairly Valued). The stock has 5 warning signs investors should review. Among 857 Medical Devices & Instruments companies, Riverstone Holdings ranks better than 91.25% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Riverstone Holdings's annualizedNet Income for the quarter that ended in Dec. 2025 was S$68.1 Mil.
Riverstone Holdings's average Total Assets over the quarter that ended in Dec. 2025 was S$514.0 Mil. Therefore, Riverstone Holdings's annualized ROA % for the quarter that ended in Dec. 2025 was 13.26%.
The historical rank and industry rank for Riverstone Holdings's ROA % or its related term are showing as below:
SGX:AP4'
s ROA % Range Over the Past 10 Years
Min: 11.05 Med: 16.03 Max: 64.26
Current: 12.21
During the past 13 years, Riverstone Holdings's highest ROA % was 64.26%. The lowest was 11.05%. And the median was 16.03%.
SGX:AP4's ROA % is ranked better than 91.25% of 857
companies
in the Medical Devices & Instruments industry
Industry Median: 0.54
vs SGX:AP4: 12.21
Riverstone Holdings (SGX:AP4) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Dec. 2025) net income data. The Revenue data used here is four times the quarterly (Dec. 2025) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Riverstone Holdings ROA % Related Terms
Riverstone Holdings ROA % Historical Data
* Premium members only.
The historical data trend for Riverstone Holdings's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Riverstone Holdings's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Riverstone Holdings ROA % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Riverstone Holdings's ROA % distribution charts can be found below:
* The bar in red indicates where Riverstone Holdings's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Dec. 2025) net income data.
ROA % is displayed in the 30-year financial page.
Riverstone Holdings (SGX:AP4) has a ROA % of 13.26% as of Dec. 2025. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Riverstone Holdings and its competitors. This is 17% below median its historical median of 16.03. Over the past decade, Riverstone Holdings' ROA % has ranged from 11.05 to 64.26. According to the industry distribution chart, Riverstone Holdings ranks #75 out of 857 companies in the Medical Devices & Instruments industry, placing it in the top 8.8%.
Is Riverstone Holdings' ROA % too high?
Riverstone Holdings' current ROA % of 13.26% is 17% below median its 10-year median of 16.03. Over the past 10 years, this metric has ranged from a low of 11.05 to a high of 64.26. The Medical Devices & Instruments industry median ROA % is 0.54. Riverstone Holdings' value of 13.26% is 2355.6% above this industry median. Based on the distribution chart, Riverstone Holdings ranks #75 out of 857 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Riverstone Holdings has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Riverstone Holdings' ROA % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Riverstone Holdings ranks #75 out of 857 companies for ROA %. This places Riverstone Holdings in the top 9% of its industry — outperforming the majority of peers. The industry median ROA % is 0.54. Riverstone Holdings' value of 13.26% is 2355.6% above this benchmark. Historically, Riverstone Holdings' own ROA % has ranged from 11.05 to 64.26 over the past decade. While the company's 10-year median is 16.03 vs. the industry median of 0.54, Riverstone Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.54, based on 857 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Riverstone Holdings's current ROA % of 13.26% is 2355.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Riverstone Holdings and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Riverstone Holdings's current ROA % is 13.26%, which is 17% below median its own 10-year median of 16.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Riverstone Holdings stock overvalued right now?
Based on GuruFocus' analysis, Riverstone Holdings (SGX:AP4) is currently considered Fairly Valued. The stock's GF Value™ is S$0.86, compared to a current price of S$0.85 — trading 1.2% below its estimated fair value. The current ROA % is 13.26%, which is 17% below median its 10-year median of 16.03 and 2355.6% above the Medical Devices & Instruments industry median of 0.54. Riverstone Holdings' overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Riverstone Holdings (SGX:AP4), the current ROA % is 13.26% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Riverstone Holdings (SGX:AP4) Overvalued in 2026?
Based on GuruFocus' analysis, Riverstone Holdings stock appears to be undervalued.
The current stock price of S$0.85 is trading 1.2% below its estimated GF Value™ of S$0.86.
GuruFocus considers Riverstone Holdings to be Fairly Valued.
Key valuation signals for SGX:AP4:
ROA %: 13.26% (17% below median its 10-year median of 16.03)
GF Value™: S$0.86 vs. price of S$0.85 (1.2% below fair value)
Industry Position: 2355.6% above the Medical Devices & Instruments median (#75 of 857)
No single metric tells the full story. See the SGX:AP4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Riverstone Holdings Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the manufacture and sales of gloves and non-glove consumables such as finger cots, static shielding bags, face masks, wipers, and packaging materials. The group's products are widely qualified and used in the Hard Disk Drive, and semiconductor industries. It operates in three segments based on its geography: Malaysia, Thailand, China, Singapore, and Others, of which the majority of its revenue comes from Malaysia.
63GF Score
Get the complete analysis for SGX:AP4
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:AP4 has been successfully added to your 
